uniQure N.V. - Ordinary Shares (QURE) Social Stream
UNIQURE NV (QURE) Price Targets From Analysts
Use the tables below to see what analysts covering UNIQURE NV think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 14 | $95 | $40 | $67.916 | $20.6 | 229.69% |
| 2021-12-10 | 14 | $95 | $40 | $68 | $20.6 | 230.1% |
| 2021-12-17 | 14 | $95 | $40 | $66.416 | $20.6 | 222.41% |
| 2022-03-01 | 13 | $95 | $40 | $66.363 | $20.6 | 222.15% |
| 2022-03-17 | 13 | $95 | $40 | $66.363 | $20.6 | 222.15% |
| 2022-03-29 | 13 | $95.001 | $40 | $66.363 | $20.6 | 222.15% |
| 2022-03-30 | 13 | $90 | $40 | $64.8 | $20.6 | 214.56% |
| 2022-04-07 | 12 | $90 | $40 | $64.8 | $20.6 | 214.56% |
| 2022-04-13 | 12 | $90 | $40 | $60.9 | $20.6 | 195.63% |
| 2022-05-02 | 12 | $90 | $40 | $59.4 | $20.6 | 188.35% |
| 2022-05-04 | 12 | $90 | $40 | $59 | $20.6 | 186.41% |
| 2022-05-05 | 12 | $90 | $37 | $56.1 | $20.6 | 172.33% |
| 2022-05-24 | 13 | $90 | $37 | $55.636 | $20.6 | 170.08% |
| 2022-07-20 | 12 | $90 | $34 | $56.3 | $20.6 | 173.3% |
| 2022-08-08 | 13 | $90 | $34 | $55.1 | $20.6 | 167.48% |
| 2022-08-10 | 13 | $90 | $24 | $50.727 | $20.6 | 146.25% |
| 2022-11-03 | 12 | $90 | $24 | $50.454 | $20.6 | 144.92% |
| 2022-11-23 | 13 | $90 | $24 | $52.818 | $20.6 | 156.4% |
| 2022-12-01 | 13 | $90 | $24 | $53 | $20.6 | 157.28% |
| 2023-01-17 | 13 | $90 | $24 | $53.181 | $20.6 | 158.16% |
| 2023-02-28 | 14 | $90 | $24 | $53.166 | $20.6 | 158.09% |
| 2023-03-08 | 13 | $90 | $24 | $54.09 | $20.6 | 162.57% |
| 2023-04-05 | 13 | $90 | $24 | $54.272 | $20.6 | 163.46% |
| 2023-05-09 | 13 | $90 | $24 | $53.454 | $20.6 | 159.49% |
| 2023-05-10 | 14 | $90 | $24 | $52.166 | $20.6 | 153.23% |
| 2023-05-16 | 14 | $90 | $24 | $51.083 | $20.6 | 147.98% |
| 2023-05-19 | 15 | $90 | $24 | $50.307 | $20.6 | 144.21% |
The Trend in the Analyst Price Target
QURE's average price target has moved down $0.15 over the prior 28 weeks.
QURE reports an average of 147.99% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-10 | 13 | 90 | 24 | 50.727 | 19.53 | 159.74% |
| 2022-11-23 | 13 | 90 | 24 | 52.818 | 26.36 | 100.37% |
| 2023-01-17 | 13 | 90 | 24 | 53.181 | 22.52 | 136.15% |
| 2023-04-05 | 14 | 90 | 24 | 54.272 | 19.41 | 179.61% |
| 2023-05-10 | 14 | 90 | 24 | 52.166 | 22.20 | 134.98% |
QURE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.27 | 12 | 2 | 1 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
Over the past 15 months, QURE's average broker recommendation rating worsened by 0.06.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for QURE as an investment opportunity.
- In the context of all US stocks, UNIQURE NV's variance in analysts' estimates is lower than -3332.47% of them.
- In the context of stocks in the mid market cap category, UNIQURE NV's number of analysts covering the stock is greater than 3518.36% of them.
- UNIQURE NV's upside potential (average analyst target price relative to current price) is greater than 3289.82% of stocks in the mid market cap category.
- UNIQURE NV's average analyst price target is higher than 2855.61% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to UNIQURE NV are XNCR, PAHC, and SAGE.
View All Top Stocks by Price Target
Is QURE a Buy, Hold or Sell? See the POWR Ratings now!